Malvinder Mohan Singh
- Executive Chairman, Fortis Healthcare, India
Degree in Economics, St Stephen’s College (Delhi); MBA, Fuqua School of Business, Duke University. Significant business interests in pharmaceutical, healthcare and financial services. Former Chief Executive Officer and Managing Director, Ranbaxy Laboratories, India's largest pharmaceutical company and the eighth largest generic company globally. Chairman, RHC Holding Pct. Chairman of the Board, Fortis Healthcare, India's leading healthcare services company. Chairman, Relegare, India's fastest-growing, integrated, financial services company. Acknowledged for entrepreneurial and out-of-the-box approach to business. Recently spearheaded a landmark deal, bringing together Ranbaxy and Daiichi Sankyo, Japan's second largest pharma innovator. Member of the Board of Visitors, Fuqua School of Business, Duke University. Member of the Board: Indian Council for Research on International Economic Relations (ICRIER); INSEAD Global India Council. Member, Board of Trade, Government of India.